Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan · Delayed Price · Currency is TWD 54.50
-0.50 (-0.91%)
Mar 26, 2026, 1:30 PM CST
TPEX:4747 Revenue
In the year 2025, Johnson Chemical Pharmaceutical Works had annual revenue of 569.77M TWD, down -6.81%. Johnson Chemical Pharmaceutical Works had revenue of 150.53M in the quarter ending December 31, 2025, with 1.83% growth.
Revenue
569.77M
Revenue Growth
-6.81%
P/S Ratio
4.30
Revenue / Employee
2.86M
Employees
199
Market Cap
2.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 569.77M | -41.64M | -6.81% |
| Dec 31, 2024 | 611.42M | 4.70M | 0.78% |
| Dec 31, 2023 | 606.71M | 112.04M | 22.65% |
| Dec 31, 2022 | 494.67M | 83.18M | 20.21% |
| Dec 31, 2021 | 411.49M | -12.52M | -2.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orient EuroPharma | 4.60B |
| Maywufa Company | 1.58B |
| TSH Biopharm Corporation | 1.34B |
| Allied Biotech | 849.51M |
| GeneFerm Biotechnology | 677.10M |
| Easywell Biomedicals | 597.41M |
| Tien Liang BioTech | 511.79M |
| PhytoHealth | 134.58M |